Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-1 Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01048671
What this trial is testing

Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 482
Large-scale testing (Phase 3)Study completedNCT01968551
What this trial is testing

Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults

Who this might be right for
HIV-1HIV InfectionsAcquired Immunodeficiency Syndrome
Gilead Sciences 158
Early research (Phase 1)Study completedNCT00002353
What this trial is testing

A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human Subjects

Who this might be right for
HIV Infections
United Biomedical
Early research (Phase 1)Study completedNCT05585307
What this trial is testing

Study of Novel Antiretrovirals in Participants With HIV-1

Who this might be right for
HIV-1-infection
Gilead Sciences 49
Large-scale testing (Phase 3)Study completedNCT00711009
What this trial is testing

Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)

Who this might be right for
Human Immunodeficiency Virus Infection
Abbott 206
Post-approval studies (Phase 4)WithdrawnNCT00782301
What this trial is testing

Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients

Who this might be right for
Hepatitis BHuman Immunodeficiency VirusHepatitis C, Chronic
ViiV Healthcare
Not applicableStudy completedNCT00000900
What this trial is testing

The Effects of Illnesses on HIV Levels in the Body

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 26
Large-scale testing (Phase 3)Study completedNCT02605954
What this trial is testing

Safety and Efficacy of Switching From Regimens of ABC/3TC + a 3rd Agent to E/C/F/TAF Fixed-Dose Combination (FDC) in Virologically-Suppressed HIV 1 Infected Adults

Who this might be right for
HIV-1 Infection
Gilead Sciences 275
Not applicableStudy completedNCT05634265
What this trial is testing

Social Media for ART Adherence and Retention in Adolescents and Young Adults: the Vijana-SMART Study

Who this might be right for
HIV-1-infectionAdherence, MedicationDepression
University of Washington 55
Post-approval studies (Phase 4)UnknownNCT02337322
What this trial is testing

Immune Recovery in Advanced , ARV-naïve, HIV-1-infected Individuals Taking Dolutegravir or Ritonavir-boosted Darunavir

Who this might be right for
Acquired Immune Deficiency Syndrome Virus
Juan A. Arnaiz 104
Early research (Phase 1)Study completedNCT03552536
What this trial is testing

MK-8583 Single Dose Study in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants (MK-8583-002)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 5
Early research (Phase 1)Study completedNCT04771754
What this trial is testing

The Effect of Dolutegravir on Whole-body Insulin Sensitivity, Lipid and Endocrine Profile in Healthy Volunteers

Who this might be right for
HIV-1-infection on Healthy Volunteers
Chelsea and Westminster NHS Foundation Trust 16
Not applicableStudy completedNCT00014937
What this trial is testing

Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 240
Testing effectiveness (Phase 2)Study completedNCT01903031
What this trial is testing

Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 84
Testing effectiveness (Phase 2)Study completedNCT00848211
What this trial is testing

Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects

Who this might be right for
HIV Infections
Thymon, LLC 24
Post-approval studies (Phase 4)Study completedNCT02236234
What this trial is testing

Immune Response to HPV Vaccine Among HIV-1-infected Subjects in Brazil

Who this might be right for
Infection
University of Sao Paulo 30
Not applicableStudy completedNCT01392430
What this trial is testing

Discontinuation of Primary and Secondary Prophylaxis for Opportunistic Infections in HIV-infected Patients

Who this might be right for
HIV Infection
Chiang Mai University 74
Not applicableStudy completedNCT03001128
What this trial is testing

Biomarkers to Predict Time to Plasma HIV RNA Rebound

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 61
Testing effectiveness (Phase 2)Study completedNCT00604175
What this trial is testing

Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women

Who this might be right for
HIV InfectionsSexually Transmitted Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 319
Post-approval studies (Phase 4)Study completedNCT00002376
What this trial is testing

The Effectiveness of HIV RNA Viral Load Testing in Determining Treatment Type in HIV-Infected Patients

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 540
Next Page